| Literature DB >> 3347355 |
J E Mollman1, W M Hogan, D J Glover, L F McCluskey.
Abstract
Symptoms and signs of cis-diamminedichloroplatinum II (DDP) neuropathy usually develop during treatment and stabilize or improve when DDP is stopped. We report three patients whose symptoms began 3 to 8 weeks after the last dose of DDP and progressed over 1 or 2 months to moderate-marked disability. The clinical picture in each was consistent with DDP neuropathy, and no other cause could be identified. Two of the patients improved over 8 and 27 months to become asymptomatic; the other died 2 months after presentation. It is important to recognize that DDP neuropathy can present after treatment has been discontinued since the clinical picture mimics the paraneoplastic dorsal root ganglionitis, which has a different prognosis.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3347355 DOI: 10.1212/wnl.38.3.488
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910